368 related articles for article (PubMed ID: 8210205)
1. [Vaccination against the enterobacteria responsible for enteric infections].
Sansonetti PJ
Ann Gastroenterol Hepatol (Paris); 1994; 30(2):60-3. PubMed ID: 8210205
[TBL] [Abstract][Full Text] [Related]
2. [Vaccination against the enterobacteriaceae responsible for enteric infections].
Sansonetti PJ
Bull Acad Natl Med; 1993 Nov; 177(8):1401-7; discussion 1407-8. PubMed ID: 8193944
[TBL] [Abstract][Full Text] [Related]
3. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
4. Oral vaccination against enteric bacterial infections: an overview.
Germanier R
Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
[TBL] [Abstract][Full Text] [Related]
5. New vaccines against bacterial enteric infections.
Holmgren J; Svennerholm AM
Scand J Infect Dis Suppl; 1990; 70():149-56. PubMed ID: 2287897
[TBL] [Abstract][Full Text] [Related]
6. [An oral enteritis-vaccine composed of twelve heat inactivated Enterobacteriaceae. 1. Communication: Theoretical and epidemiological considerations (author's transl)].
Raettig H
Zentralbl Bakteriol Orig A; 1979; 245(3):287-300. PubMed ID: 44783
[TBL] [Abstract][Full Text] [Related]
7. Future vaccines against enteric pathogens.
Levine MM; Edelman R
Infect Dis Clin North Am; 1990 Mar; 4(1):105-21. PubMed ID: 2155260
[TBL] [Abstract][Full Text] [Related]
8. [Vaccination against diarrheal diseases and typhoid fever. Current status and prospects].
Ivanoff B; Neira M
Ann Med Interne (Paris); 1998 Oct; 149(6):340-50. PubMed ID: 9853044
[TBL] [Abstract][Full Text] [Related]
9. [An oral enteritis-vaccine composed of twelve heat-inactivated Enterobacteriaceae 3. Communication: studies on efficacy tests in mice protection tests (author's transl)].
Raettig H
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):511-20. PubMed ID: 7036591
[TBL] [Abstract][Full Text] [Related]
10. [Oral vaccines for preventing intestinal infections (literature review)].
Kheĭfets LB
Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):21-8. PubMed ID: 4208437
[No Abstract] [Full Text] [Related]
11. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use.
Joó I
Dev Biol Stand; 1976; 33():75-9. PubMed ID: 782974
[TBL] [Abstract][Full Text] [Related]
12. [Construction of a typhoid-dysentery bivalent strain with typhoid ty21a and dysentery T32-Istrati strains].
Chen QY; Jiang LJ; Kong DC; Wang BR
Wei Sheng Wu Xue Bao; 1987 Dec; 27(4):362-8. PubMed ID: 3329424
[No Abstract] [Full Text] [Related]
13. Bacterial enteric infections and vaccine development.
Holmgren J; Svennerholm AM
Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
[TBL] [Abstract][Full Text] [Related]
14. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.
Walker RI
Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361
[TBL] [Abstract][Full Text] [Related]
15. [Vaccines inf the prevention of fecal hazards].
Saliou P
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
17. [The role of immunization against bacterial enteric infections (author's transl)].
Rey M
Med Trop (Mars); 1979; 39(4):457-62. PubMed ID: 537492
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
[No Abstract] [Full Text] [Related]
20. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
